Bluevine reports 2025 saw a rebound for small businesses, with admin services, education, retail, and health sectors thriving ...

Bristol-Myers Squibb raised FY 2025 guidance, with operating EPS targeted at $6.40–$6.60 and net sales above consensus. Click here to find out why BMY is a Buy.

Salesforce's (NYSE: CRM) stock chart shows another clear indication that now may be a good time to buy it. The latest signal ...

Pure Storage (PSTG) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider ...

NIGHT price faces a key January 2026 test as whale buying clashes with rising Midnight exchange supply. Big money decides the ...

Bristol-Myers Squibb Company is rated a Buy with solid rebound and robust free cash flow margins. Learn more about BMY stock ...

Artificial intelligence has quickly become a fixture in healthcare conversations, particularly around clinical documentation, workforce efficiency ...

Researchers created a nationally consistent, publicly available dataset estimating car-based driving times and distances to ...

AltaGas' estimated fair value is CA$70.96 based on 2 Stage Free Cash Flow to Equity. AltaGas is estimated to be 42% undervalued based on current share price of CA$41 ...

Some requests by reviewers to cite their own publications are coercive and can unnecessarily delay indexation and publication.

Investors haven’t exactly sold the news on Waste Management Inc. (NYSE: WM), but recent price action suggests they want to see headlines translate into increased profits. In 2025, Waste ...

Recent commentary highlighted Trane Technologies’ role in helping industrial facilities move from fossil fuel-based heating to integrated, electrified thermal management systems, using heat pump ...